
Emmanuelle Rémond
32
Documents
Publications
Publications
Silicon-containing amino acids for 18F labeling of neurotensin analogues targeting NTS1 receptor37th European Peptide Symposium (37th EPS) & 14th International Peptide Symposium (14th IPS), European Peptide Society (EPS), Aug 2024, Florence, Italy. pp.98-99
Communication dans un congrès
hal-04811528
v1
|
|
Dual 68Ga-labeled peptide-based radiopharmaceuticals to address tumor heterogeneity37th European Peptide Symposium (37th EPS) & 14th International Peptide Symposium (14th IPS), European Peptide Society (EPS), Aug 2024, Florence, Italy. pp.42
Communication dans un congrès
hal-04811498
v1
|
|
Hybrid synthetic approach and biological characterization of a branched heterodimer for overcoming prostate cancer heterogeneity37th European Peptide Symposium (37th EPS) & 14th International Peptide Symposium (14th IPS), European Peptide Society (EPS), Aug 2024, Florence, Italy. pp.146-147
Communication dans un congrès
hal-04811469
v1
|
|
Radiometal modification of JMV6659 for theranostic approach of NTS1 targetingAnnual Congress of the European Association of Nuclear Medicine (EANM’23), European Association of Nuclear Medicine (EANM), Sep 2023, Vienne, Austria. pp.S399 / OP-895
Communication dans un congrès
hal-04833746
v1
|
|
Radiometal modification of JMV6659 for theranostic approach of NTS1 targeting.Annual Congress of the European Association of Nuclear Medicine , Sep 2023, Vienna, Austria
Communication dans un congrès
hal-04933338
v1
|
|
P-functionalized fluorescent phospholes for chemoselective coupling to peptides under mild conditions22e GFPP/BPGM5, French-Belgian Joint Meeting, GFPP; BPGM, May 2022, Port Leucate, France
Communication dans un congrès
hal-04815048
v1
|
|
Optimization of radiopharmaceuticals based on neurotensin [8-13] for NTS1-positive tumours imaging.Virtual meeting Italy, Dec 2020, Virtual conference, France
Communication dans un congrès
hal-04933253
v1
|
|
Novel radiopharmaceutical neurotensin analogues as potential agents for cancer theranostic21ème Réunion Peptides, May 2019, Amboise, France
Communication dans un congrès
hal-04933128
v1
|
|
Development and optimization of novel radiolabelled neurotensin analogues for NTS1-positive tumours theranostic.GPCR international meeting, Oct 2019, Montpellier, France
Communication dans un congrès
hal-04933192
v1
|
|
Novel radiolabelled neurotensin analogues containing silylated amino acid for improved neurotensin receptor-1 (NTS1) targeting32. Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), European-Association-of-Nuclear-Medicine (EANM), Oct 2019, Barcelone, Spain
Communication dans un congrès
hal-02899963
v1
|
Development of neurotensin analogues stabilized by Lys8-Lys9 reduction and linker modificationsAnnual Congress of the European Association of Nuclear Medicine (EANM’23), Sep 2023, Vienne, Austria. Springer, European Journal of Nuclear Medicine and Molecular Imaging, 50 (S1), pp.S445 / EP-0035, 2023, EANM’23 Abstract Book Congress Sep 9-13, 2023
Poster de conférence
hal-04833589
v1
|
|
Neurotensin, a short peptide of multiple interests36th European Peptide Symposium & 12th International Peptide Symposium, Aug 2022, Sitges (Barcelona), Spain. Wiley, Journal of Peptide Science, 28 (S3), pp.P085, 2022
Poster de conférence
hal-04834400
v1
|
|
P-functionalized fluorescent phospholes for chemioselective peptide labeling under mild conditions36th European Peptide Symposium & 12th International Peptide Symposium, Aug 2022, Sitges (Barcelona), Spain. Wiley, Journal of Peptide Science, 28 (S3), pp.P412, 2022
Poster de conférence
hal-04834734
v1
|
Chargement...
Chargement...